BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 32543879)

  • 41. Late therapeutic intervention with a respiratory syncytial virus L-protein polymerase inhibitor, PC786, on respiratory syncytial virus infection in human airway epithelium.
    Brookes DW; Coates M; Allen H; Daly L; Constant S; Huang S; Hows M; Davis A; Cass L; Ayrton J; Knowles I; Strong P; Rapeport G; Ito K
    Br J Pharmacol; 2018 Jun; 175(12):2520-2534. PubMed ID: 29579332
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Performance of the Alere i RSV assay for point-of-care detection of respiratory syncytial virus in children.
    Schnee SV; Pfeil J; Ihling CM; Tabatabai J; Schnitzler P
    BMC Infect Dis; 2017 Dec; 17(1):767. PubMed ID: 29237419
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunological and Inflammatory Biomarkers of Susceptibility and Severity in Adult Respiratory Syncytial Virus Infections.
    Wiseman DJ; Thwaites RS; Drysdale SB; Janet S; Donaldson GC; Wedzicha JA; Openshaw PJ;
    J Infect Dis; 2020 Oct; 222(Suppl 7):S584-S591. PubMed ID: 32227102
    [TBL] [Abstract][Full Text] [Related]  

  • 44. ISG15 Is Upregulated in Respiratory Syncytial Virus Infection and Reduces Virus Growth through Protein ISGylation.
    González-Sanz R; Mata M; Bermejo-Martín J; Álvarez A; Cortijo J; Melero JA; Martínez I
    J Virol; 2016 Jan; 90(7):3428-38. PubMed ID: 26763998
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long Noncoding RNA NRAV Promotes Respiratory Syncytial Virus Replication by Targeting the MicroRNA miR-509-3p/Rab5c Axis To Regulate Vesicle Transportation.
    Li J; Li M; Wang X; Sun M; Ma C; Liang W; Gao X; Wei L
    J Virol; 2020 May; 94(10):. PubMed ID: 32102886
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multiple Respiratory Syncytial Virus (RSV) Strains Infecting HEp-2 and A549 Cells Reveal Cell Line-Dependent Differences in Resistance to RSV Infection.
    Rajan A; Piedra FA; Aideyan L; McBride T; Robertson M; Johnson HL; Aloisio GM; Henke D; Coarfa C; Stossi F; Menon VK; Doddapaneni H; Muzny DM; Javornik Cregeen SJ; Hoffman KL; Petrosino J; Gibbs RA; Avadhanula V; Piedra PA
    J Virol; 2022 Apr; 96(7):e0190421. PubMed ID: 35285685
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development of an allosteric inhibitor class blocking RNA elongation by the respiratory syncytial virus polymerase complex.
    Cox RM; Toots M; Yoon JJ; Sourimant J; Ludeke B; Fearns R; Bourque E; Patti J; Lee E; Vernachio J; Plemper RK
    J Biol Chem; 2018 Oct; 293(43):16761-16777. PubMed ID: 30206124
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MUC5AC Levels Associated With Respiratory Syncytial Virus Disease Severity.
    Rajan D; O'Keefe EL; Travers C; McCracken C; Geoghegan S; Caballero MT; Acosta PL; Polack F; Anderson LJ
    Clin Infect Dis; 2018 Oct; 67(9):1441-1444. PubMed ID: 29878077
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Exchange Proteins Directly Activated by cAMP and Their Roles in Respiratory Syncytial Virus Infection.
    Choi EJ; Ren Y; Chen Y; Liu S; Wu W; Ren J; Wang P; Garofalo RP; Zhou J; Bao X
    J Virol; 2018 Nov; 92(22):. PubMed ID: 30185593
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of quantitative and type-specific real-time RT-PCR assays for detection of respiratory syncytial virus in respiratory specimens from children.
    Kuypers J; Wright N; Morrow R
    J Clin Virol; 2004 Oct; 31(2):123-9. PubMed ID: 15364268
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human metapneumovirus in lung transplant recipients and comparison to respiratory syncytial virus.
    Hopkins P; McNeil K; Kermeen F; Musk M; McQueen E; Mackay I; Sloots T; Nissen M
    Am J Respir Crit Care Med; 2008 Oct; 178(8):876-81. PubMed ID: 18658110
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Leflunomide prevents alveolar fluid clearance inhibition by respiratory syncytial virus.
    Davis IC; Lazarowski ER; Hickman-Davis JM; Fortenberry JA; Chen FP; Zhao X; Sorscher E; Graves LM; Sullender WM; Matalon S
    Am J Respir Crit Care Med; 2006 Mar; 173(6):673-82. PubMed ID: 16387801
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Survey of diagnostic testing for respiratory syncytial virus (RSV) in adults: Infectious disease physician practices and implications for burden estimates.
    Allen KE; Beekmann SE; Polgreen P; Poser S; St Pierre J; Santibañez S; Gerber SI; Kim L
    Diagn Microbiol Infect Dis; 2018 Nov; 92(3):206-209. PubMed ID: 30177420
    [TBL] [Abstract][Full Text] [Related]  

  • 54. New therapies for acute RSV infections: where are we?
    Xing Y; Proesmans M
    Eur J Pediatr; 2019 Feb; 178(2):131-138. PubMed ID: 30610420
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High pneumococcal density correlates with more mucosal inflammation and reduced respiratory syncytial virus disease severity in infants.
    Vissers M; Ahout IM; van den Kieboom CH; van der Gaast-de Jongh CE; Groh L; Cremers AJ; de Groot R; de Jonge MI; Ferwerda G
    BMC Infect Dis; 2016 Mar; 16():129. PubMed ID: 26983753
    [TBL] [Abstract][Full Text] [Related]  

  • 56. m
    Picavet LW; van Vroonhoven ECN; Scholman RC; Smits YTH; Banerjee R; Besteman SB; Viveen MC; van der Vlist MM; Tanenbaum ME; Lebbink RJ; Vastert SJ; van Loosdregt J
    Viruses; 2024 May; 16(5):. PubMed ID: 38793659
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Respiratory syncytial virus shedding by children hospitalized with lower respiratory tract infection.
    Takeyama A; Hashimoto K; Sato M; Kawashima R; Kawasaki Y; Hosoya M
    J Med Virol; 2016 Jun; 88(6):938-46. PubMed ID: 26588816
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Haemophilus is overrepresented in the nasopharynx of infants hospitalized with RSV infection and associated with increased viral load and enhanced mucosal CXCL8 responses.
    Ederveen THA; Ferwerda G; Ahout IM; Vissers M; de Groot R; Boekhorst J; Timmerman HM; Huynen MA; van Hijum SAFT; de Jonge MI
    Microbiome; 2018 Jan; 6(1):10. PubMed ID: 29325581
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Targeting Intracellular Ion Homeostasis for the Control of Respiratory Syncytial Virus.
    Norris MJ; Malhi M; Duan W; Ouyang H; Granados A; Cen Y; Tseng YC; Gubbay J; Maynes J; Moraes TJ
    Am J Respir Cell Mol Biol; 2018 Dec; 59(6):733-744. PubMed ID: 30095982
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intranasal administration of maleic anhydride-modified human serum albumin for pre-exposure prophylaxis of respiratory syncytial virus infection.
    Sun Z; Wang Q; Jia R; Xia S; Li Y; Liu Q; Xu W; Xu J; Du L; Lu L; Jiang S
    Viruses; 2015 Feb; 7(2):798-819. PubMed ID: 25690799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.